The biotechnology scene in Asia is rapidly growing and has become a major player in the biotech industry globally. And in recent years, Singapore has also become a hub for biomedical startups.
Vishal Doshi, Chairman & CEO, AUM Biosciences shares how he is paving the way for disruption in Asia’s biotech landscape and oncology drug space.

The Big Story: Is Singapore at risk of becoming a “human prop” in the age of AI?
13:52

What's Trending: Was this public figure's Instagram really deleted .. and smart underwear that counts your farts?
14:27

Wealth Tracker: Is there still an institutional appetite for Solana despite a 40% decline?
07:55